Albuquerque, NM, United States of America

Hadya M Khawaja

USPTO Granted Patents = 1 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Hadya M Khawaja: A Pioneer in Cancer Treatment

Introduction: Hadya M Khawaja, an inventive force based in Albuquerque, NM, is recognized for her groundbreaking contributions to cancer treatment through her innovative patent. With one registered patent to her name, she is making significant strides in the realm of pharmaceuticals, specifically targeting cancer-associated diseases.

Latest Patents: Khawaja's sole patent, titled "Selective efflux inhibitors and related pharmaceutical compositions and methods of treatment," focuses on pyrazolo[1,5-a]pyrimidine compounds. These compounds are designed to inhibit cancer-associated transporter proteins, which play a critical role in drug resistance in various cancers. The invention outlines methods for treating or preventing diseases linked to these transporter proteins by administering selective efflux inhibitors that favorably target ABCG2 over ABCB1. This innovative approach aims to effectively combat drug-resistant and multiple-drug-resistant cancers, offering new hope for patients struggling with these challenging conditions.

Career Highlights: Throughout her career, Hadya M Khawaja has worked with reputable institutions, including the University of New Mexico (STC.UNM) and the University of Kansas. Her experience in these environments has allowed her to advance her research in pharmaceutical development and contribute to the scientific community significantly.

Collaborations: During her professional journey, Khawaja has collaborated with esteemed colleagues, including Richard Smith Larson and Larry A Sklar. These collaborations have enriched her research endeavors and furthered the development of her innovative cancer treatment strategies.

Conclusion: Hadya M Khawaja stands as a notable inventor whose work in developing selective efflux inhibitors is paving the way for new treatments in oncology. Her dedication to innovation and collaboration exemplifies the spirit of scientific discovery, establishing her as a key player in the field of pharmaceutical sciences. With her continued research efforts, Khawaja is poised to make even greater contributions to the fight against cancer, potentially transforming the therapeutic landscape for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…